Continental Chemicals（506935）株式概要コンチネンタル・ケミカルズ社は、コンピューター・プログラミング、コンサルタント、関連サービスを提供している。 詳細506935 ファンダメンタル分析スノーフレーク・スコア評価1/6将来の成長0/6過去の実績5/6財務の健全性6/6配当金0/6報酬株価収益率（ 22.2 x） Indian市場（ 23.3 x）を下回っています。過去1年間で収益は65.1%増加しました リスク分析収益が 100 万ドル未満 ( ₹2M )株式の流動性は非常に低い 意味のある時価総額がありません ( ₹131M )すべてのリスクチェックを見る506935 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value₹Current Price₹58.25181.3% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture06m2016201920222025202620282031Revenue ₹1.6mEarnings ₹4.1mAdvancedSet Fair ValueView all narrativesContinental Chemicals Limited 競合他社ERP Soft SystemsSymbol: BSE:530909Market cap: ₹237.6mMahaveer InfowaySymbol: BSE:539383Market cap: ₹66.1mCosynSymbol: BSE:538922Market cap: ₹162.5mBenchmark Computer SolutionsSymbol: BSE:544052Market cap: ₹161.3m価格と性能株価の高値、安値、推移の概要Continental Chemicals過去の株価現在の株価₹58.2552週高値₹87.0852週安値₹56.89ベータ-0.591ヶ月の変化-3.72%3ヶ月変化-25.68%1年変化-17.83%3年間の変化-15.93%5年間の変化340.29%IPOからの変化1,356.25%最新ニュースお知らせ • May 20Continental Chemicals Limited to Report Q4, 2026 Results on May 30, 2026Continental Chemicals Limited announced that they will report Q4, 2026 results at 12:15 PM, Indian Standard Time on May 30, 2026Valuation Update With 7 Day Price Move • Jan 19Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹74.08, the stock trades at a trailing P/E ratio of 28.2x. Average trailing P/E is 25x in the IT industry in India. Total loss to shareholders of 11% over the past three years.Reported Earnings • Jan 13Third quarter 2026 earnings released: EPS: ₹0.60 (vs ₹0.43 in 3Q 2025)Third quarter 2026 results: EPS: ₹0.60 (up from ₹0.43 in 3Q 2025). Net income: ₹1.34m (up 38% from 3Q 2025). Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.お知らせ • Jan 05Continental Chemicals Limited Announces Resignation of Navneet Kumar as Chief Financial Officer, Effective January 14, 2026Continental Chemicals Limited announced that Mr. Navneet Kumar has resigned from the position of Chief Financial Officer. Mr. Navneet Kumar submitted his resignation on December 13, 2025 due to personal reasons in view of his decision to pursue another career opportunity, with the resignation effective from January 14, 2026. The company submitted intimation in this regard to BSE on December 13, 2025.お知らせ • Jan 03Continental Chemicals Limited to Report Q3, 2026 Results on Jan 12, 2026Continental Chemicals Limited announced that they will report Q3, 2026 results at 12:15 PM, Indian Standard Time on Jan 12, 2026New Risk • Nov 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m (₹2.3m revenue, or US$26k). Market cap is less than US$10m (₹157.4m market cap, or US$1.77m). Minor Risk Share price has been volatile over the past 3 months (6.9% average weekly change).最新情報をもっと見るRecent updatesお知らせ • May 20Continental Chemicals Limited to Report Q4, 2026 Results on May 30, 2026Continental Chemicals Limited announced that they will report Q4, 2026 results at 12:15 PM, Indian Standard Time on May 30, 2026Valuation Update With 7 Day Price Move • Jan 19Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹74.08, the stock trades at a trailing P/E ratio of 28.2x. Average trailing P/E is 25x in the IT industry in India. Total loss to shareholders of 11% over the past three years.Reported Earnings • Jan 13Third quarter 2026 earnings released: EPS: ₹0.60 (vs ₹0.43 in 3Q 2025)Third quarter 2026 results: EPS: ₹0.60 (up from ₹0.43 in 3Q 2025). Net income: ₹1.34m (up 38% from 3Q 2025). Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.お知らせ • Jan 05Continental Chemicals Limited Announces Resignation of Navneet Kumar as Chief Financial Officer, Effective January 14, 2026Continental Chemicals Limited announced that Mr. Navneet Kumar has resigned from the position of Chief Financial Officer. Mr. Navneet Kumar submitted his resignation on December 13, 2025 due to personal reasons in view of his decision to pursue another career opportunity, with the resignation effective from January 14, 2026. The company submitted intimation in this regard to BSE on December 13, 2025.お知らせ • Jan 03Continental Chemicals Limited to Report Q3, 2026 Results on Jan 12, 2026Continental Chemicals Limited announced that they will report Q3, 2026 results at 12:15 PM, Indian Standard Time on Jan 12, 2026New Risk • Nov 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m (₹2.3m revenue, or US$26k). Market cap is less than US$10m (₹157.4m market cap, or US$1.77m). Minor Risk Share price has been volatile over the past 3 months (6.9% average weekly change).お知らせ • Nov 05Continental Chemicals Limited to Report Q2, 2026 Results on Nov 13, 2025Continental Chemicals Limited announced that they will report Q2, 2026 results on Nov 13, 2025お知らせ • Aug 26Continental Chemicals Limited, Annual General Meeting, Sep 20, 2025Continental Chemicals Limited, Annual General Meeting, Sep 20, 2025, at 16:00 Indian Standard Time.Reported Earnings • Aug 09First quarter 2026 earnings released: EPS: ₹0.64 (vs ₹0.50 in 1Q 2025)First quarter 2026 results: EPS: ₹0.64 (up from ₹0.50 in 1Q 2025). Net income: ₹1.44m (up 29% from 1Q 2025). Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.お知らせ • Aug 06Continental Chemicals Limited Announces Reconstitution of Audit Committee, Nomination and Remuneration Committee and Stakeholders Relationship CommitteeContinental Chemicals Limited at its board meeting held on August 6, 2025 approved Reconstitution of Audit Committee, Nomination and Remuneration Committee and Stakeholders Relationship Committee. In reference to the above mentioned subject, please take note that the Board of Directors of the Company has made the following changes in the Composition of the Committees. Audit Committee: Previous Composition: Mr. Raghav Nathani - Chairperson; Naresh Kumar Chibba - Member Mr. Gaurav Sachdeva - Member. Changed Composition: Mrs. Parul Suraiya- Chairperson; Mr. Naresh Kumar Chibba - Member; Mr. Gaurav Sachdeva - Member. Nomination and Remuneration Committee: Previous Composition: Mr. Raghav Nathani - Chairperson; Mr. Gaurav Sachdeva Member; Ms.Sunaina Chibba- Member. Ms. Sunaina Chibba- Member. Changed composition: Mrs. Parul Suraiya- Chairperson; Mr. Gaurav Sachdeva Member; Ms. Sunaina Chibba-- Member. Stakeholders Relationship Committee: Previous Composition: Mr. Raghav Nathani -Chairperson; Mr. Naresh Kumar Chibba - Member Mr. Aditya Vikram Chibba- Member. Changed composition: Mrs. Parul Suraiya- Chairperson; Mr. Naresh Kumar Chibba- Member; Mr. Aditya Vikram Chibba- Member.お知らせ • Jul 30Continental Chemicals Limited to Report Q1, 2026 Results on Aug 08, 2025Continental Chemicals Limited announced that they will report Q1, 2026 results on Aug 08, 2025Reported Earnings • May 18Full year 2025 earnings released: EPS: ₹1.94 (vs ₹2.30 in FY 2024)Full year 2025 results: EPS: ₹1.94 (down from ₹2.30 in FY 2024). Revenue: ₹15.7m (up 271% from FY 2024). Net income: ₹4.36m (down 16% from FY 2024). Profit margin: 28% (down from 122% in FY 2024). Over the last 3 years on average, earnings per share has increased by 49% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings.New Risk • May 18New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 28% Last year net profit margin: 122% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (35% accrual ratio). Revenue is less than US$1m (₹16m revenue, or US$184k). Market cap is less than US$10m (₹164.6m market cap, or US$1.92m). Minor Risk Profit margins are more than 30% lower than last year (28% net profit margin).お知らせ • May 10Continental Chemicals Limited to Report Q4, 2025 Results on May 17, 2025Continental Chemicals Limited announced that they will report Q4, 2025 results on May 17, 2025Reported Earnings • Feb 05Third quarter 2025 earnings released: EPS: ₹0.43 (vs ₹0.78 in 3Q 2024)Third quarter 2025 results: EPS: ₹0.43 (down from ₹0.78 in 3Q 2024). Net income: ₹975.0k (down 44% from 3Q 2024). Over the last 3 years on average, earnings per share has increased by 48% per year but the company’s share price has fallen by 19% per year, which means it is significantly lagging earnings.お知らせ • Jan 28Continental Chemicals Limited to Report Q3, 2025 Results on Feb 03, 2025Continental Chemicals Limited announced that they will report Q3, 2025 results on Feb 03, 2025Valuation Update With 7 Day Price Move • Dec 05Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹86.25, the stock trades at a trailing P/E ratio of 32.3x. Average trailing P/E is 36x in the IT industry in India. Total loss to shareholders of 75% over the past three years.お知らせ • Nov 05Continental Chemicals Limited to Report Q2, 2025 Results on Nov 12, 2024Continental Chemicals Limited announced that they will report Q2, 2025 results on Nov 12, 2024Valuation Update With 7 Day Price Move • Oct 11Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹90.02, the stock trades at a trailing P/E ratio of 38.8x. Average trailing P/E is 41x in the IT industry in India. Total loss to shareholders of 77% over the past three years.お知らせ • Aug 26Continental Chemicals Limited, Annual General Meeting, Sep 20, 2024Continental Chemicals Limited, Annual General Meeting, Sep 20, 2024, at 16:00 Indian Standard Time.Reported Earnings • Aug 11First quarter 2025 earnings released: EPS: ₹0.50 (vs ₹0.50 in 1Q 2024)First quarter 2025 results: EPS: ₹0.50 (in line with 1Q 2024). Net income: ₹1.12m (flat on 1Q 2024). Over the last 3 years on average, earnings per share has increased by 45% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.お知らせ • Aug 01Continental Chemicals Limited to Report Q1, 2025 Results on Aug 09, 2024Continental Chemicals Limited announced that they will report Q1, 2025 results on Aug 09, 2024Reported Earnings • May 19Full year 2024 earnings released: EPS: ₹2.30 (vs ₹1.11 in FY 2023)Full year 2024 results: EPS: ₹2.30 (up from ₹1.11 in FY 2023). Revenue: ₹15.7m (up 259% from FY 2023). Net income: ₹5.18m (up 108% from FY 2023). Profit margin: 33% (down from 57% in FY 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has increased by 79% per year, which means it is tracking significantly ahead of earnings growth.New Risk • May 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m (₹3.7m revenue, or US$45k). Market cap is less than US$10m (₹163.4m market cap, or US$1.96m). Minor Risk Share price has been volatile over the past 3 months (8.4% average weekly change).Reported Earnings • Jan 23Third quarter 2024 earnings released: EPS: ₹0.78 (vs ₹0.66 in 3Q 2023)Third quarter 2024 results: EPS: ₹0.78 (up from ₹0.66 in 3Q 2023). Revenue: ₹4.47m (up 145% from 3Q 2023). Net income: ₹1.75m (up 18% from 3Q 2023). Profit margin: 39% (down from 81% in 3Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has increased by 70% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Jan 16Continental Chemicals Limited to Report Q3, 2024 Results on Jan 22, 2024Continental Chemicals Limited announced that they will report Q3, 2024 results on Jan 22, 2024お知らせ • Nov 01Continental Chemicals Limited to Report Q2, 2024 Results on Nov 09, 2023Continental Chemicals Limited announced that they will report Q2, 2024 results on Nov 09, 2023Valuation Update With 7 Day Price Move • Sep 08Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹73.60, the stock trades at a trailing P/E ratio of 66.4x. Average trailing P/E is 36x in the IT industry in India. Total returns to shareholders of 287% over the past three years.Reported Earnings • Aug 26Full year 2023 earnings released: EPS: ₹1.11 (vs ₹0.27 in FY 2022)Full year 2023 results: EPS: ₹1.11 (up from ₹0.27 in FY 2022). Revenue: ₹12.7m (up 165% from FY 2022). Net income: ₹2.49m (up 316% from FY 2022). Profit margin: 20% (up from 13% in FY 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has increased by 49% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Aug 26Continental Chemicals Limited, Annual General Meeting, Sep 20, 2023Continental Chemicals Limited, Annual General Meeting, Sep 20, 2023, at 16:00 Indian Standard Time. Agenda: To receive, consider and adopt the Board's Report for the year ended 31 March 2023, audited Statement of Profit and Loss for the year, Balance Sheet as on that date, and the Report of the Auditors thereon; to consider and appoint a director in place of Mr. Aditya Vikram Chibba, who retires by rotation and being eligible, offers himself for re-appointment; to consider resolution to be passed under Section 180(1) of the Companies Act, 2013 to sell, lease, transfer, convey, assign or otherwise to dispose; and to consider any other matters of the company's immovable properties.New Risk • Aug 07New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m (₹4.4m revenue, or US$53k). Market cap is less than US$10m (₹150.2m market cap, or US$1.82m). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Share price has been volatile over the past 3 months (7.8% average weekly change).お知らせ • Aug 01Continental Chemicals Limited Appoints Navneet Kumar as the Chief Financial OfficerContinental Chemicals Limited Board of Directors of the Company in their Board meeting held i.e., 31 July, 2023 appointed Mr. Navneet Kumar as the Chief Financial Officer of the company. effective from 31 July, 2023. Brief profile: Mr. Navneet Kumar is appointed as the -- chief Financial Officer of the company in the capacity of Key Managerial Personnel w.e.f 31 July, 2023, Mr. Navneet Kumar is appointed as per the terms and conditions contained in his appointment letter. Mr. Navneet Kumar holds MBA Degree in Finance & Marketing from the prestigious University UPTU, Lucknow. He also have rich working experience in Finance and Accounts.お知らせ • Jul 25Continental Chemicals Limited to Report Q1, 2024 Results on Jul 31, 2023Continental Chemicals Limited announced that they will report Q1, 2024 results on Jul 31, 2023お知らせ • May 20Continental Chemicals Limited to Report Q4, 2023 Results on May 29, 2023Continental Chemicals Limited announced that they will report Q4, 2023 results at 3:30 PM, Indian Standard Time on May 29, 2023お知らせ • Jan 28Continental Chemicals Limited to Report Q3, 2023 Results on Feb 04, 2023Continental Chemicals Limited announced that they will report Q3, 2023 results at 3:30 PM, Indian Standard Time on Feb 04, 2023お知らせ • Jan 18Continental Chemicals Limited Announces Resignation of Nitesh Rai as Chief Financial OfficerContinental Chemicals Limited announced that Mr. Nitesh Rai has resigned from the post of CFO of the Continental Chemicals Limited on 16 January, 2023 due to personal reasons.Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Akshat Bhaskar was the last independent director to join the board, commencing their role in 2014. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Nov 13Second quarter 2023 earnings released: EPS: ₹0.31 (vs ₹0.32 in 2Q 2022)Second quarter 2023 results: EPS: ₹0.31 (down from ₹0.32 in 2Q 2022). Revenue: ₹3.24m (up 95% from 2Q 2022). Net income: ₹685.0k (down 5.0% from 2Q 2022). Profit margin: 21% (down from 44% in 2Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 174 percentage points per year, which is a significant difference in performance.お知らせ • Nov 05Continental Chemicals Limited to Report Q2, 2023 Results on Nov 11, 2022Continental Chemicals Limited announced that they will report Q2, 2023 results on Nov 11, 2022お知らせ • Aug 28Continental Chemicals Limited, Annual General Meeting, Sep 20, 2022Continental Chemicals Limited, Annual General Meeting, Sep 20, 2022, at 16:00 Indian Standard Time. Agenda: To receive, consider and adopt the Board's Report for the year ended 31% March 2022, audited Statement of Profit and Loss for the year, Balance Sheet as on that date, and the Report of the Auditors thereon; to appoint a director in place of Ms. Sunaina Chibba, who retires by rotation and being eligible, offers herself for re-appointment; to consider and approve reappointment of Mr. Naresh Kumar Chibba as Managing Director of the Company; and to consider other issues.Reported Earnings • Aug 10First quarter 2023 earnings released: EPS: ₹0.35 (vs ₹0.15 in 1Q 2022)First quarter 2023 results: EPS: ₹0.35 (up from ₹0.15 in 1Q 2022). Revenue: ₹3.16m (up 165% from 1Q 2022). Net income: ₹797.0k (up 141% from 1Q 2022). Profit margin: 25% (down from 28% in 1Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 187 percentage points per year, which is a significant difference in performance.お知らせ • Jul 31Continental Chemicals Limited to Report Q1, 2023 Results on Aug 08, 2022Continental Chemicals Limited announced that they will report Q1, 2023 results on Aug 08, 2022お知らせ • Jul 01Continental Chemicals Limited Appoints Mr. Nitesh Rai as the Chief Financial Officer, With Effect from June 30, 2022Continental Chemicals Limited appointed Mr. Nitesh Rai as the Chief Financial Officer of the company. Mr. Nitesh Rai is appointed as the chief Financial Officer of the company in the capacity of Key Managerial Personnel with effect from June 30, 2022, Mr. Nitesh Rai is appointed as per the terms and conditions contained in his appointment letter. Mr. Nitesh Rai holds graduation degree in B.com (Hons) from the prestigious college of Delhi university. He also have rich working experience in Finance and Accounts.お知らせ • Jun 09Continental Chemicals Limited Announces the Resignation of Puneet Kumar as Chief Financial Officer (CFO)Continental Chemicals Limited announced the resignation of Puneet Kumar as Chief Financial Officer (CFO), with effect from June 7, 2022, due to personal reasons.お知らせ • May 16Continental Chemicals Limited to Report Q4, 2022 Results on May 21, 2022Continental Chemicals Limited announced that they will report Q4, 2022 results on May 21, 2022Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Akshat Bhaskar was the last independent director to join the board, commencing their role in 2014. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Feb 17Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹0.21 (up from ₹0.02 in 3Q 2021). Revenue: ₹3.51m (up 294% from 3Q 2021). Net income: ₹467.0k (up ₹422.0k from 3Q 2021). Profit margin: 13% (up from 5.0% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 53% per year but the company’s share price has increased by 155% per year, which means it is well ahead of earnings.お知らせ • Jan 30Continental Chemicals Limited to Report Q3, 2022 Results on Feb 05, 2022Continental Chemicals Limited announced that they will report Q3, 2022 results on Feb 05, 2022Board Change • Dec 15Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Akshat Bhaskar was the last independent director to join the board, commencing their role in 2014. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Nov 11Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Akshat Bhaskar was the last independent director to join the board, commencing their role in 2014. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Oct 25Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Akshat Bhaskar was the last independent director to join the board, commencing their role in 2014. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Aug 03First quarter 2022 earnings released: EPS ₹0.15 (vs ₹0.05 in 1Q 2021)The company reported a solid first quarter result with improved earnings and revenues, although profit margins were weaker. First quarter 2022 results: Revenue: ₹2.21m (up 350% from 1Q 2021). Net income: ₹331.0k (up 176% from 1Q 2021). Profit margin: 15% (down from 25% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has increased by 88% per year, which means it is well ahead of earnings.Executive Departure • Jul 23Company Secretary & Compliance Officer Bhawna Gupta has left the companyOn the 15th of July, Bhawna Gupta's tenure as Company Secretary & Compliance Officer ended after less than a year in the role. We don't have any record of a personal shareholding under Bhawna's name. Bhawna is the only executive to leave the company over the last 12 months.Valuation Update With 7 Day Price Move • Jul 14Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹30.45, the stock trades at a trailing P/E ratio of 47.6x. Average trailing P/E is 31x in the IT industry in India. Total returns to shareholders of 253% over the past three years.Reported Earnings • Jun 21Full year 2021 earnings released: EPS ₹0.64 (vs ₹0.49 in FY 2020)The company reported a solid full year result with improved earnings and revenues, although profit margins were weaker. Full year 2021 results: Revenue: ₹9.68m (up 210% from FY 2020). Net income: ₹1.43m (up 84% from FY 2020). Profit margin: 15% (down from 25% in FY 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has increased by 31% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Jun 19Investor sentiment improved over the past weekAfter last week's 21% share price gain to ₹17.70, the stock trades at a trailing P/E ratio of 70.4x. Average trailing P/E is 29x in the IT industry in India. Total returns to shareholders of 116% over the past three years.Is New 90 Day High Low • Feb 10New 90-day low: ₹13.36The company is down 30% from its price of ₹19.00 on 12 November 2020. The Indian market is up 21% over the last 90 days, indicating the company underperformed over that time. It also underperformed the IT industry, which is up 20% over the same period.Reported Earnings • Feb 07Third quarter 2021 earnings released: EPS ₹0.02 (vs ₹0.07 loss in 3Q 2020)Third quarter 2021 results: Net income: ₹45.0k (up ₹145.0k from 3Q 2020). Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has increased by 34% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Feb 07Continental Chemicals Limited Appoints Puneet Kumar as CFOContinental Chemicals Limited announced that, Mr. Puneet Kumar has been appointed as CFO of the company in the Board Meeting held on February 6, 2021 with effect from February 6, 2021.お知らせ • Feb 01Continental Chemicals Limited to Report Q3, 2021 Results on Feb 06, 2021Continental Chemicals Limited announced that they will report Q3, 2021 results on Feb 06, 2021Valuation Update With 7 Day Price Move • Jan 20Investor sentiment deteriorated over the past weekAfter last week's 22% share price decline to ₹15.55, the stock is trading at a trailing P/E ratio of 51.7x, down from the previous P/E ratio of 66.2x. This compares to an average P/E of 22x in the IT industry in India. Total returns to shareholders over the past three years are 153%.お知らせ • Nov 27Continental Chemicals Limited, Annual General Meeting, Dec 21, 2020Continental Chemicals Limited, Annual General Meeting, Dec 21, 2020, at 16:30 Indian Standard Time. Agenda: To receive, consider and adopt the Board's report for the year ended March 31, 2020, audited statement of profit and loss for the year, Balance Sheet as on that date, and report of the Auditors thereon; to appoint a Director in place of Ms. Sunaina Chibba (DIN: 00370454), who retires by rotation and being eligible, offers herself for re-appointment; and to consider Regularization of Mr. Aditya Vikram Chibba (DIN: 02838045) As Director of the Company, to consider and if thought fit, to pass, with or without modification.お知らせ • Nov 07Continental Chemicals Limited to Report Q2, 2021 Results on Nov 12, 2020Continental Chemicals Limited announced that they will report Q2, 2021 results on Nov 12, 2020株主還元506935IN ITIN 市場7D-4.9%3.8%0.5%1Y-17.8%-26.6%-0.5%株主還元を見る業界別リターン: 506935過去 1 年間で-26.6 % の収益を上げたIndian IT業界を上回りました。リターン対市場: 506935は、過去 1 年間で-0.5 % のリターンを上げたIndian市場を下回りました。価格変動Is 506935's price volatile compared to industry and market?506935 volatility506935 Average Weekly Movementn/aIT Industry Average Movement8.0%Market Average Movement7.1%10% most volatile stocks in IN Market10.1%10% least volatile stocks in IN Market4.8%安定した株価: 506935の株価は、 Indian市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 過去 1 年間の506935のボラティリティの変化を判断するには データが不十分です。会社概要設立従業員CEO（最高経営責任者ウェブサイト19848Naresh Chibbawww.continentalchemicalsltd.comコンチネンタル・ケミカルズ社は、コンピューター・プログラミング、コンサルタント、関連サービスを提供している。完全なCMSを備えたイベントウェブサイト、ダイナミックな審査と論文募集を備えたアワードウェブサイト、会議管理システム、オンラインマニュアル、モバイルアプリとモバイルウェブサイト、インタラクティブなフロアプランとイベントルートプランナーなどのオンラインソリューションを提供している。また、ソフトウェアの購入、販売、ライセンス供与のほか、ホスティング、コンサルタント、販売、トレーニングサービスの提供にも携わっている。インド、米国、英国、ヨーロッパ、アフリカ、中東、中国、シンガポール、香港、オーストラリアで事業を展開している。コンチネンタル・ケミカルズは1984年に設立され、インドのノイダを拠点としている。もっと見るContinental Chemicals Limited 基礎のまとめContinental Chemicals の収益と売上を時価総額と比較するとどうか。506935 基礎統計学時価総額₹131.00m収益（TTM）₹5.91m売上高(TTM)₹2.37m22.2xPER（株価収益率55.3xP/Sレシオ506935 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計506935 損益計算書（TTM）収益₹2.37m売上原価₹7.62m売上総利益-₹5.25mその他の費用-₹11.16m収益₹5.91m直近の収益報告Dec 31, 2025次回決算日May 30, 2026一株当たり利益（EPS）2.63グロス・マージン-221.53%純利益率249.56%有利子負債／自己資本比率0.6%506935 の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/23 10:26終値2026/05/19 00:00収益2025/12/31年間収益2025/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Continental Chemicals Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • May 20Continental Chemicals Limited to Report Q4, 2026 Results on May 30, 2026Continental Chemicals Limited announced that they will report Q4, 2026 results at 12:15 PM, Indian Standard Time on May 30, 2026
Valuation Update With 7 Day Price Move • Jan 19Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹74.08, the stock trades at a trailing P/E ratio of 28.2x. Average trailing P/E is 25x in the IT industry in India. Total loss to shareholders of 11% over the past three years.
Reported Earnings • Jan 13Third quarter 2026 earnings released: EPS: ₹0.60 (vs ₹0.43 in 3Q 2025)Third quarter 2026 results: EPS: ₹0.60 (up from ₹0.43 in 3Q 2025). Net income: ₹1.34m (up 38% from 3Q 2025). Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.
お知らせ • Jan 05Continental Chemicals Limited Announces Resignation of Navneet Kumar as Chief Financial Officer, Effective January 14, 2026Continental Chemicals Limited announced that Mr. Navneet Kumar has resigned from the position of Chief Financial Officer. Mr. Navneet Kumar submitted his resignation on December 13, 2025 due to personal reasons in view of his decision to pursue another career opportunity, with the resignation effective from January 14, 2026. The company submitted intimation in this regard to BSE on December 13, 2025.
お知らせ • Jan 03Continental Chemicals Limited to Report Q3, 2026 Results on Jan 12, 2026Continental Chemicals Limited announced that they will report Q3, 2026 results at 12:15 PM, Indian Standard Time on Jan 12, 2026
New Risk • Nov 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m (₹2.3m revenue, or US$26k). Market cap is less than US$10m (₹157.4m market cap, or US$1.77m). Minor Risk Share price has been volatile over the past 3 months (6.9% average weekly change).
お知らせ • May 20Continental Chemicals Limited to Report Q4, 2026 Results on May 30, 2026Continental Chemicals Limited announced that they will report Q4, 2026 results at 12:15 PM, Indian Standard Time on May 30, 2026
Valuation Update With 7 Day Price Move • Jan 19Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹74.08, the stock trades at a trailing P/E ratio of 28.2x. Average trailing P/E is 25x in the IT industry in India. Total loss to shareholders of 11% over the past three years.
Reported Earnings • Jan 13Third quarter 2026 earnings released: EPS: ₹0.60 (vs ₹0.43 in 3Q 2025)Third quarter 2026 results: EPS: ₹0.60 (up from ₹0.43 in 3Q 2025). Net income: ₹1.34m (up 38% from 3Q 2025). Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.
お知らせ • Jan 05Continental Chemicals Limited Announces Resignation of Navneet Kumar as Chief Financial Officer, Effective January 14, 2026Continental Chemicals Limited announced that Mr. Navneet Kumar has resigned from the position of Chief Financial Officer. Mr. Navneet Kumar submitted his resignation on December 13, 2025 due to personal reasons in view of his decision to pursue another career opportunity, with the resignation effective from January 14, 2026. The company submitted intimation in this regard to BSE on December 13, 2025.
お知らせ • Jan 03Continental Chemicals Limited to Report Q3, 2026 Results on Jan 12, 2026Continental Chemicals Limited announced that they will report Q3, 2026 results at 12:15 PM, Indian Standard Time on Jan 12, 2026
New Risk • Nov 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m (₹2.3m revenue, or US$26k). Market cap is less than US$10m (₹157.4m market cap, or US$1.77m). Minor Risk Share price has been volatile over the past 3 months (6.9% average weekly change).
お知らせ • Nov 05Continental Chemicals Limited to Report Q2, 2026 Results on Nov 13, 2025Continental Chemicals Limited announced that they will report Q2, 2026 results on Nov 13, 2025
お知らせ • Aug 26Continental Chemicals Limited, Annual General Meeting, Sep 20, 2025Continental Chemicals Limited, Annual General Meeting, Sep 20, 2025, at 16:00 Indian Standard Time.
Reported Earnings • Aug 09First quarter 2026 earnings released: EPS: ₹0.64 (vs ₹0.50 in 1Q 2025)First quarter 2026 results: EPS: ₹0.64 (up from ₹0.50 in 1Q 2025). Net income: ₹1.44m (up 29% from 1Q 2025). Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.
お知らせ • Aug 06Continental Chemicals Limited Announces Reconstitution of Audit Committee, Nomination and Remuneration Committee and Stakeholders Relationship CommitteeContinental Chemicals Limited at its board meeting held on August 6, 2025 approved Reconstitution of Audit Committee, Nomination and Remuneration Committee and Stakeholders Relationship Committee. In reference to the above mentioned subject, please take note that the Board of Directors of the Company has made the following changes in the Composition of the Committees. Audit Committee: Previous Composition: Mr. Raghav Nathani - Chairperson; Naresh Kumar Chibba - Member Mr. Gaurav Sachdeva - Member. Changed Composition: Mrs. Parul Suraiya- Chairperson; Mr. Naresh Kumar Chibba - Member; Mr. Gaurav Sachdeva - Member. Nomination and Remuneration Committee: Previous Composition: Mr. Raghav Nathani - Chairperson; Mr. Gaurav Sachdeva Member; Ms.Sunaina Chibba- Member. Ms. Sunaina Chibba- Member. Changed composition: Mrs. Parul Suraiya- Chairperson; Mr. Gaurav Sachdeva Member; Ms. Sunaina Chibba-- Member. Stakeholders Relationship Committee: Previous Composition: Mr. Raghav Nathani -Chairperson; Mr. Naresh Kumar Chibba - Member Mr. Aditya Vikram Chibba- Member. Changed composition: Mrs. Parul Suraiya- Chairperson; Mr. Naresh Kumar Chibba- Member; Mr. Aditya Vikram Chibba- Member.
お知らせ • Jul 30Continental Chemicals Limited to Report Q1, 2026 Results on Aug 08, 2025Continental Chemicals Limited announced that they will report Q1, 2026 results on Aug 08, 2025
Reported Earnings • May 18Full year 2025 earnings released: EPS: ₹1.94 (vs ₹2.30 in FY 2024)Full year 2025 results: EPS: ₹1.94 (down from ₹2.30 in FY 2024). Revenue: ₹15.7m (up 271% from FY 2024). Net income: ₹4.36m (down 16% from FY 2024). Profit margin: 28% (down from 122% in FY 2024). Over the last 3 years on average, earnings per share has increased by 49% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings.
New Risk • May 18New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 28% Last year net profit margin: 122% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (35% accrual ratio). Revenue is less than US$1m (₹16m revenue, or US$184k). Market cap is less than US$10m (₹164.6m market cap, or US$1.92m). Minor Risk Profit margins are more than 30% lower than last year (28% net profit margin).
お知らせ • May 10Continental Chemicals Limited to Report Q4, 2025 Results on May 17, 2025Continental Chemicals Limited announced that they will report Q4, 2025 results on May 17, 2025
Reported Earnings • Feb 05Third quarter 2025 earnings released: EPS: ₹0.43 (vs ₹0.78 in 3Q 2024)Third quarter 2025 results: EPS: ₹0.43 (down from ₹0.78 in 3Q 2024). Net income: ₹975.0k (down 44% from 3Q 2024). Over the last 3 years on average, earnings per share has increased by 48% per year but the company’s share price has fallen by 19% per year, which means it is significantly lagging earnings.
お知らせ • Jan 28Continental Chemicals Limited to Report Q3, 2025 Results on Feb 03, 2025Continental Chemicals Limited announced that they will report Q3, 2025 results on Feb 03, 2025
Valuation Update With 7 Day Price Move • Dec 05Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹86.25, the stock trades at a trailing P/E ratio of 32.3x. Average trailing P/E is 36x in the IT industry in India. Total loss to shareholders of 75% over the past three years.
お知らせ • Nov 05Continental Chemicals Limited to Report Q2, 2025 Results on Nov 12, 2024Continental Chemicals Limited announced that they will report Q2, 2025 results on Nov 12, 2024
Valuation Update With 7 Day Price Move • Oct 11Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹90.02, the stock trades at a trailing P/E ratio of 38.8x. Average trailing P/E is 41x in the IT industry in India. Total loss to shareholders of 77% over the past three years.
お知らせ • Aug 26Continental Chemicals Limited, Annual General Meeting, Sep 20, 2024Continental Chemicals Limited, Annual General Meeting, Sep 20, 2024, at 16:00 Indian Standard Time.
Reported Earnings • Aug 11First quarter 2025 earnings released: EPS: ₹0.50 (vs ₹0.50 in 1Q 2024)First quarter 2025 results: EPS: ₹0.50 (in line with 1Q 2024). Net income: ₹1.12m (flat on 1Q 2024). Over the last 3 years on average, earnings per share has increased by 45% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.
お知らせ • Aug 01Continental Chemicals Limited to Report Q1, 2025 Results on Aug 09, 2024Continental Chemicals Limited announced that they will report Q1, 2025 results on Aug 09, 2024
Reported Earnings • May 19Full year 2024 earnings released: EPS: ₹2.30 (vs ₹1.11 in FY 2023)Full year 2024 results: EPS: ₹2.30 (up from ₹1.11 in FY 2023). Revenue: ₹15.7m (up 259% from FY 2023). Net income: ₹5.18m (up 108% from FY 2023). Profit margin: 33% (down from 57% in FY 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has increased by 79% per year, which means it is tracking significantly ahead of earnings growth.
New Risk • May 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m (₹3.7m revenue, or US$45k). Market cap is less than US$10m (₹163.4m market cap, or US$1.96m). Minor Risk Share price has been volatile over the past 3 months (8.4% average weekly change).
Reported Earnings • Jan 23Third quarter 2024 earnings released: EPS: ₹0.78 (vs ₹0.66 in 3Q 2023)Third quarter 2024 results: EPS: ₹0.78 (up from ₹0.66 in 3Q 2023). Revenue: ₹4.47m (up 145% from 3Q 2023). Net income: ₹1.75m (up 18% from 3Q 2023). Profit margin: 39% (down from 81% in 3Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has increased by 70% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Jan 16Continental Chemicals Limited to Report Q3, 2024 Results on Jan 22, 2024Continental Chemicals Limited announced that they will report Q3, 2024 results on Jan 22, 2024
お知らせ • Nov 01Continental Chemicals Limited to Report Q2, 2024 Results on Nov 09, 2023Continental Chemicals Limited announced that they will report Q2, 2024 results on Nov 09, 2023
Valuation Update With 7 Day Price Move • Sep 08Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹73.60, the stock trades at a trailing P/E ratio of 66.4x. Average trailing P/E is 36x in the IT industry in India. Total returns to shareholders of 287% over the past three years.
Reported Earnings • Aug 26Full year 2023 earnings released: EPS: ₹1.11 (vs ₹0.27 in FY 2022)Full year 2023 results: EPS: ₹1.11 (up from ₹0.27 in FY 2022). Revenue: ₹12.7m (up 165% from FY 2022). Net income: ₹2.49m (up 316% from FY 2022). Profit margin: 20% (up from 13% in FY 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has increased by 49% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Aug 26Continental Chemicals Limited, Annual General Meeting, Sep 20, 2023Continental Chemicals Limited, Annual General Meeting, Sep 20, 2023, at 16:00 Indian Standard Time. Agenda: To receive, consider and adopt the Board's Report for the year ended 31 March 2023, audited Statement of Profit and Loss for the year, Balance Sheet as on that date, and the Report of the Auditors thereon; to consider and appoint a director in place of Mr. Aditya Vikram Chibba, who retires by rotation and being eligible, offers himself for re-appointment; to consider resolution to be passed under Section 180(1) of the Companies Act, 2013 to sell, lease, transfer, convey, assign or otherwise to dispose; and to consider any other matters of the company's immovable properties.
New Risk • Aug 07New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m (₹4.4m revenue, or US$53k). Market cap is less than US$10m (₹150.2m market cap, or US$1.82m). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Share price has been volatile over the past 3 months (7.8% average weekly change).
お知らせ • Aug 01Continental Chemicals Limited Appoints Navneet Kumar as the Chief Financial OfficerContinental Chemicals Limited Board of Directors of the Company in their Board meeting held i.e., 31 July, 2023 appointed Mr. Navneet Kumar as the Chief Financial Officer of the company. effective from 31 July, 2023. Brief profile: Mr. Navneet Kumar is appointed as the -- chief Financial Officer of the company in the capacity of Key Managerial Personnel w.e.f 31 July, 2023, Mr. Navneet Kumar is appointed as per the terms and conditions contained in his appointment letter. Mr. Navneet Kumar holds MBA Degree in Finance & Marketing from the prestigious University UPTU, Lucknow. He also have rich working experience in Finance and Accounts.
お知らせ • Jul 25Continental Chemicals Limited to Report Q1, 2024 Results on Jul 31, 2023Continental Chemicals Limited announced that they will report Q1, 2024 results on Jul 31, 2023
お知らせ • May 20Continental Chemicals Limited to Report Q4, 2023 Results on May 29, 2023Continental Chemicals Limited announced that they will report Q4, 2023 results at 3:30 PM, Indian Standard Time on May 29, 2023
お知らせ • Jan 28Continental Chemicals Limited to Report Q3, 2023 Results on Feb 04, 2023Continental Chemicals Limited announced that they will report Q3, 2023 results at 3:30 PM, Indian Standard Time on Feb 04, 2023
お知らせ • Jan 18Continental Chemicals Limited Announces Resignation of Nitesh Rai as Chief Financial OfficerContinental Chemicals Limited announced that Mr. Nitesh Rai has resigned from the post of CFO of the Continental Chemicals Limited on 16 January, 2023 due to personal reasons.
Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Akshat Bhaskar was the last independent director to join the board, commencing their role in 2014. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Nov 13Second quarter 2023 earnings released: EPS: ₹0.31 (vs ₹0.32 in 2Q 2022)Second quarter 2023 results: EPS: ₹0.31 (down from ₹0.32 in 2Q 2022). Revenue: ₹3.24m (up 95% from 2Q 2022). Net income: ₹685.0k (down 5.0% from 2Q 2022). Profit margin: 21% (down from 44% in 2Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 174 percentage points per year, which is a significant difference in performance.
お知らせ • Nov 05Continental Chemicals Limited to Report Q2, 2023 Results on Nov 11, 2022Continental Chemicals Limited announced that they will report Q2, 2023 results on Nov 11, 2022
お知らせ • Aug 28Continental Chemicals Limited, Annual General Meeting, Sep 20, 2022Continental Chemicals Limited, Annual General Meeting, Sep 20, 2022, at 16:00 Indian Standard Time. Agenda: To receive, consider and adopt the Board's Report for the year ended 31% March 2022, audited Statement of Profit and Loss for the year, Balance Sheet as on that date, and the Report of the Auditors thereon; to appoint a director in place of Ms. Sunaina Chibba, who retires by rotation and being eligible, offers herself for re-appointment; to consider and approve reappointment of Mr. Naresh Kumar Chibba as Managing Director of the Company; and to consider other issues.
Reported Earnings • Aug 10First quarter 2023 earnings released: EPS: ₹0.35 (vs ₹0.15 in 1Q 2022)First quarter 2023 results: EPS: ₹0.35 (up from ₹0.15 in 1Q 2022). Revenue: ₹3.16m (up 165% from 1Q 2022). Net income: ₹797.0k (up 141% from 1Q 2022). Profit margin: 25% (down from 28% in 1Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 187 percentage points per year, which is a significant difference in performance.
お知らせ • Jul 31Continental Chemicals Limited to Report Q1, 2023 Results on Aug 08, 2022Continental Chemicals Limited announced that they will report Q1, 2023 results on Aug 08, 2022
お知らせ • Jul 01Continental Chemicals Limited Appoints Mr. Nitesh Rai as the Chief Financial Officer, With Effect from June 30, 2022Continental Chemicals Limited appointed Mr. Nitesh Rai as the Chief Financial Officer of the company. Mr. Nitesh Rai is appointed as the chief Financial Officer of the company in the capacity of Key Managerial Personnel with effect from June 30, 2022, Mr. Nitesh Rai is appointed as per the terms and conditions contained in his appointment letter. Mr. Nitesh Rai holds graduation degree in B.com (Hons) from the prestigious college of Delhi university. He also have rich working experience in Finance and Accounts.
お知らせ • Jun 09Continental Chemicals Limited Announces the Resignation of Puneet Kumar as Chief Financial Officer (CFO)Continental Chemicals Limited announced the resignation of Puneet Kumar as Chief Financial Officer (CFO), with effect from June 7, 2022, due to personal reasons.
お知らせ • May 16Continental Chemicals Limited to Report Q4, 2022 Results on May 21, 2022Continental Chemicals Limited announced that they will report Q4, 2022 results on May 21, 2022
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Akshat Bhaskar was the last independent director to join the board, commencing their role in 2014. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Feb 17Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹0.21 (up from ₹0.02 in 3Q 2021). Revenue: ₹3.51m (up 294% from 3Q 2021). Net income: ₹467.0k (up ₹422.0k from 3Q 2021). Profit margin: 13% (up from 5.0% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 53% per year but the company’s share price has increased by 155% per year, which means it is well ahead of earnings.
お知らせ • Jan 30Continental Chemicals Limited to Report Q3, 2022 Results on Feb 05, 2022Continental Chemicals Limited announced that they will report Q3, 2022 results on Feb 05, 2022
Board Change • Dec 15Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Akshat Bhaskar was the last independent director to join the board, commencing their role in 2014. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Nov 11Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Akshat Bhaskar was the last independent director to join the board, commencing their role in 2014. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Oct 25Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Akshat Bhaskar was the last independent director to join the board, commencing their role in 2014. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Aug 03First quarter 2022 earnings released: EPS ₹0.15 (vs ₹0.05 in 1Q 2021)The company reported a solid first quarter result with improved earnings and revenues, although profit margins were weaker. First quarter 2022 results: Revenue: ₹2.21m (up 350% from 1Q 2021). Net income: ₹331.0k (up 176% from 1Q 2021). Profit margin: 15% (down from 25% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has increased by 88% per year, which means it is well ahead of earnings.
Executive Departure • Jul 23Company Secretary & Compliance Officer Bhawna Gupta has left the companyOn the 15th of July, Bhawna Gupta's tenure as Company Secretary & Compliance Officer ended after less than a year in the role. We don't have any record of a personal shareholding under Bhawna's name. Bhawna is the only executive to leave the company over the last 12 months.
Valuation Update With 7 Day Price Move • Jul 14Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹30.45, the stock trades at a trailing P/E ratio of 47.6x. Average trailing P/E is 31x in the IT industry in India. Total returns to shareholders of 253% over the past three years.
Reported Earnings • Jun 21Full year 2021 earnings released: EPS ₹0.64 (vs ₹0.49 in FY 2020)The company reported a solid full year result with improved earnings and revenues, although profit margins were weaker. Full year 2021 results: Revenue: ₹9.68m (up 210% from FY 2020). Net income: ₹1.43m (up 84% from FY 2020). Profit margin: 15% (down from 25% in FY 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has increased by 31% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Jun 19Investor sentiment improved over the past weekAfter last week's 21% share price gain to ₹17.70, the stock trades at a trailing P/E ratio of 70.4x. Average trailing P/E is 29x in the IT industry in India. Total returns to shareholders of 116% over the past three years.
Is New 90 Day High Low • Feb 10New 90-day low: ₹13.36The company is down 30% from its price of ₹19.00 on 12 November 2020. The Indian market is up 21% over the last 90 days, indicating the company underperformed over that time. It also underperformed the IT industry, which is up 20% over the same period.
Reported Earnings • Feb 07Third quarter 2021 earnings released: EPS ₹0.02 (vs ₹0.07 loss in 3Q 2020)Third quarter 2021 results: Net income: ₹45.0k (up ₹145.0k from 3Q 2020). Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has increased by 34% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Feb 07Continental Chemicals Limited Appoints Puneet Kumar as CFOContinental Chemicals Limited announced that, Mr. Puneet Kumar has been appointed as CFO of the company in the Board Meeting held on February 6, 2021 with effect from February 6, 2021.
お知らせ • Feb 01Continental Chemicals Limited to Report Q3, 2021 Results on Feb 06, 2021Continental Chemicals Limited announced that they will report Q3, 2021 results on Feb 06, 2021
Valuation Update With 7 Day Price Move • Jan 20Investor sentiment deteriorated over the past weekAfter last week's 22% share price decline to ₹15.55, the stock is trading at a trailing P/E ratio of 51.7x, down from the previous P/E ratio of 66.2x. This compares to an average P/E of 22x in the IT industry in India. Total returns to shareholders over the past three years are 153%.
お知らせ • Nov 27Continental Chemicals Limited, Annual General Meeting, Dec 21, 2020Continental Chemicals Limited, Annual General Meeting, Dec 21, 2020, at 16:30 Indian Standard Time. Agenda: To receive, consider and adopt the Board's report for the year ended March 31, 2020, audited statement of profit and loss for the year, Balance Sheet as on that date, and report of the Auditors thereon; to appoint a Director in place of Ms. Sunaina Chibba (DIN: 00370454), who retires by rotation and being eligible, offers herself for re-appointment; and to consider Regularization of Mr. Aditya Vikram Chibba (DIN: 02838045) As Director of the Company, to consider and if thought fit, to pass, with or without modification.
お知らせ • Nov 07Continental Chemicals Limited to Report Q2, 2021 Results on Nov 12, 2020Continental Chemicals Limited announced that they will report Q2, 2021 results on Nov 12, 2020
